Oxygenta Pharmaceutical Ltd. - Research Center
524636 OXYGENTAPH Group (X) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 39.64 | 30.99 | 60.52 | 52.03 | 13.72 |
| Expenses | |||||
| Material consumed | 34.02 | 24.03 | 47.87 | 37.66 | 16.30 |
| Manufacturing expenses | 6.95 | 11.18 | 4.81 | 4.64 | 1.44 |
| Personnel expenses | 5.99 | 1.24 | 4.60 | 4.21 | 2.50 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 2.38 | 1.65 | 1.78 | 1.68 | 1.35 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 49.34 | 38.10 | 59.05 | 48.18 | 21.58 |
| Operating profit | -9.70 | -7.12 | 1.48 | 3.84 | -7.87 |
| Other recurring income | 0.04 | 0.02 | - | 0.09 | 0.03 |
| Adjusted PBDIT | -9.65 | -7.10 | 1.48 | 3.93 | -7.83 |
| Financial expenses | 1.59 | 1.49 | 0.92 | 1.78 | 1.09 |
| Depreciation | 2.66 | 2.05 | 1.59 | 1.20 | 1.00 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | -13.91 | -10.64 | -1.04 | 0.95 | -9.93 |
| Tax charges | -10.39 | 0.20 | 0.12 | 0.21 | -0.15 |
| Adjusted PAT | -3.52 | -10.84 | -1.16 | 0.74 | -9.77 |
| Non recurring items | 0.11 | -0.73 | 0.55 | 2.19 | 3.99 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | -3.41 | -11.57 | -0.61 | 2.93 | -5.79 |
| Earnigs before appropriation | -63.81 | -60.40 | -48.83 | -48.22 | -51.15 |
| Equity dividend | - | - | - | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | -63.81 | -60.40 | -48.83 | -48.22 | -51.15 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis